Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Tazarotene

EU orphan designation number: EU/3/06/423   
Active ingredient: Tazarotene
Indication: Treatment of congenital ichthyoses
Sponsor: Orfagen
CRDPF Langlade, 3 avenue Hubert Curien, BP 13562, F-31035 Toulouse CEDEX 1, France

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
20/12/2006 Centralised Orphan - Designation EMEA/OD/073/06 (2006)7018 of 18/12/2006
30/05/2011 Other procedure EMEA/OD/073/06